semiglutide or tirzepatide Semaglutide vs Tirzepatide: Which GLP-1 Wins for Weight Loss? Semaglutide vs Tirzepatide, which is

GLP-1-induced nausea and satiety often reduce daily fluid intake, creating a dual pressure on kidney function that can spike uric acid to levels exceeding the solubility threshold needed to form monosodium urate crystals

A formulation buffered at pH 7.4 with appropriate stabilizing excipients will last longer than one compounded at a lower pH without the same level of formulation science behind it

Based on these findings, TE resulted in an average weight loss of about 4% over a period of more than 14 weeks, without requiring patients to follow a specific diet or lifestyle program

Tirzepatide works on two hormone receptors (GIP + GLP-1) while semaglutide only targets GLP-1